Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

So far, Altmetric has seen 13 tweets from 12 users, with an upper bound of 22,828 followers.

#JITC Research: Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma https://t.co/Fb7mjszuQr https://t.co/5sjwTVc6AS

RT @jitcancer: New #JITC Research: Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metas…

RT @jitcancer: New #JITC Research: Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metas…

RT @jitcancer: New #JITC Research: Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metas…

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 9 additional tweets.